---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-033756"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2024-08-23T23:59:59+00:00"
generated_at: "2026-05-31T07:53:25.831467+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Tevogen Bio raises $6M via Series C Preferred; director Suren Ajjarapu resigns

## Summary
- Sold 600 shares of Series C Preferred at $10,000 each for $6.0M aggregate to The Patel Family, LLP.
- Series C carries 7.5% annual cumulative dividend, convertible after 6 months at VWAP floor $0.6172.
- Conversion subject to 9.99% beneficial ownership limitation; pre-funded warrants issued if exceeded.
- Director Suren Ajjarapu resigned effective August 21, 2024, with no disagreement with the company.
- Proceeds from unregistered sale used for general corporate purposes; stock not registered under Securities Act.

## SEC filing metadata
- accession: 0001493152-24-033756
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2024-08-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 5.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000149315224033756/0001493152-24-033756-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000149315224033756/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-033756
- JSON: https://secwatch.observer/filing/0001493152-24-033756.json
- Plain text: https://secwatch.observer/filing/0001493152-24-033756.txt

## Key facts
- Executive change
  Suren Ajjarapu resigned as Director at Tevogen Bio Holdings Inc..
  - Action: resigned
  - Role: Director
  source text: On August 20, 2024, Suren Ajjarapu gave notice of his resignation from service as a director of the Company, effective August 21, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860871/000149315224033756/0001493152-24-033756-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.